Structural Heart Devices Market is Projected to Register 10.2% CAGR to 2023

“The structural heart devices market is projected to register a CAGR of 10.2% during the forecast period.”

The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%. The rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases are the major factors driving the growth of the structural heart devices market.


Request a Free Sample copy of This Premium Research Report:


“The replacement procedures segment is projected to register the highest CAGR during the forecast period.”

Based on procedure, the structural heart devices market is segmented replacement procedures and repair procedures. The replacement procedures segment is further segmented into TAVR procedures and SAVR procedures, while the repair procedures segment is subdivided into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures. The replacement procedures segment is expected to register the highest CAGR during the forecast period. This can be attributed to the long-term durability of these procedures and the widespread preference for transcatheter replacement.


“Asia Pacific to witness the highest growth during the forecast period.”

The structural heart devices market in the Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as the rising geriatric population, favorable reimbursement scenario, increasing regulatory approvals, the presence of a large target patient population, increasing healthcare expenditure, implementation of government-funded insurance schemes, and the growing medical tourism industry in several APAC countries are expected to drive the growth of the Asia Pacific structural heart devices market.


Read More about this report:


Break of primary participants is mentioned below:

  • By Company Type: Tier 1 – 62%, Tier 2 – 28%, and Tier 3 – 10%
  • By Designation: C-level – 30%, Director Level – 13%, and Others – 57%
  • By Region: North America – 38%, Europe – 20%, Asia Pacific – 30%, and the RoW – 12%,


The major players operating in the structural heart devices market are Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK).


Related Report:

Abdominal Surgical Robots Market Shares Strategies and Forecasts Worldwide 2017-2023

WinterGreen Research announces that it has published a new study Abdominal Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2017 to 2023. The 2017 study has 524 pages, 202 tables and figures. Worldwide Abdominal Surgical Robot markets are expected to achieve significant growth as robots replace open surgery in treatment of abdominal disease conditions. Visualization of the surgical site is improving, giving surgeons better insight into the surgical site. The robots permit a more accurate and steadier cutting than is possible with open surgery.


Read More:


 About Us:

We are a leading market research store (headquartered in The Hague, Netherlands) bringing to you market research insights, analysis and data from many market research publishers around the globe.

Our experienced market research consultants understand a client’s research requirements in precise manner and get as many proposals around the globe as possible on the table suiting your budget and mapping your research goals.

Our only motivation is to provide clients with precise insights into their respective niche markets and offering them the most comprehensive portfolio of business information products.



Watchers of Markets

Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.


Phone number: +31- 85 888 111 6

Email Id : [email protected]

Posted by on Friday September 14 2018, 9:20 AM EDT. All trademarks acknowledged. Filed under Biotechnology, Diagnostics, Featured Press Release, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in